Evotec has published its Sustainability Report 2022. In reference to the GRI standards and for the first time partially audited, it is a testament to our progress made in shaping a resilient and sustainable business together with our partners, designed to cope with and to seize future opportunities from a variety of challenges today.
In cooperation with our partners, we focus on discovering, developing and manufacturing medicines that matter, thereby positively impacting patients’ lives with cures and access to new therapies. This is our greatest contribution to the stabilisation of societies, economies, and healthcare systems around the world. The claim #researchneverstops, therefore, expresses our ambition to act sustainably in every aspect of our activities to fulfil this purpose.
We invite all our stakeholders to take a thorough look into the document and we more than welcome any feedback that you may have. We look forward to a continuous dialogue over the course of 2023!
The next opportunity to learn more our sustainability strategy and our contribution to a better future for next generations is our virtual Capital Markets Day, scheduled for 5 June. The replay of the event as well as the presentation will be shared with the broader group of stakeholders shortly after the event.
This announcement contains forward-looking statements concerning future events, including the proposed offering and listing of Evotec’s securities. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “should,” “target,” “would” and variations of such words and similar expressions are intended to identify forward-looking statements. Such statements include comments regarding Evotec’s expectations for revenues, Group EBITDA and unpartnered R&D expenses. These forward-looking statements are based on the information available to, and the expectations and assumptions deemed reasonable by Evotec at the time these statements were made. No assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of Evotec. Evotec expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Evotec’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.